PAR Sterile Products

2 recalls •

💊 Drugs

• Categories: Prescription Drugs

Treprostinil Injection, 20 mg/20 mL (1 mg/mL), For Subcutaneous or Intravenous Infusion Only, 20 mL Multiple-Dose Vial, Rx Only, Distributed by: Par Pharmaceutical, Chestnut Ridge, NY 10977. NDC: 42023-206-01

Class I - Dangerous

Presence of Particulate Matter.

Mar 4, 2024 Prescription Drugs Nationwide View Details →

Vasostrict (vasopressin in 5% Dextrose) Injection, 20 units per 100 mL (0.2 units per mL), 100 mL x 10 Single Dose Vials per carton, Ready to Use, For Intravenous Infusion, Rx Only, Distributed by: Par Pharmaceutical, Chestnut Ridge, NY 10977. NDC: 42023-237-10

Class I - Dangerous

Superpotent Drug: Assay from the 3-month and 6-month stability intervals exceeded the upper specification limit.

Jan 11, 2024 Prescription Drugs Nationwide View Details →

Buprenorphine HCl, Injection, 0.3mg/mL, For Intramuscular or Intravenous Use, Rx Only, 1mL Single Dose Vial, (supplied in packages of 5 vials) Distributed by Par Pharmaceutical, Chestnut Ridge, NY 10977, NDC: 42023-179-05

Class I - Dangerous

Crystallization: presence of white, crystalline product agglomeration observed in 2 vials during annual inspection of retain samples.

Nov 9, 2021 Prescription Drugs Nationwide View Details →

Buprenorphine HCI Injection, 0.3 mg/mL, 1 mL Single Dose Vial (NDC 42023-179-01), packaged in 1 mL x 5 Single Dose Vials per carton (NDC 42023-179-05), Rx Only, Distributed by: Par Pharmaceuticals Companies, Inc., Spring Valley, NY 10977.

Class I - Dangerous

Crystallization: due to the presence of white, crystalline particulates, adhered to the side and bottom of the glass vials, which are comprised of principally dextrose and the buprenorphine active component.

Apr 28, 2017 Prescription Drugs Nationwide View Details →